Clonidine displacement from type 1 imidazoline receptor by p-aminobenzamidine, the prototype of trypsin-like serine protease inhibitors

IUBMB Life

Volumn 54, Issue 5, 2002, Pages 301-304

  Pallottini, Valentina ^a   Marino, Maria ^a   Ascenzi, Paolo ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

Agmatine; Clonidine; N amidino 2 hydroxypyrrolidine; p aminobenzamidine; Type 1 imidazoline receptor

Indexed keywords

4 AMINOBENZAMIDINE; AGMATINE; ANTIHYPERTENSIVE AGENT; CLONIDINE; IMIDAZOLINE RECEPTOR; N AMIDINO 2 HYDROXYPYRROLIDINE; RECEPTOR SUBTYPE; SERINE PROTEINASE INHIBITOR; TRITIUM; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR EFFECT; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HYPERTENSION; MALE; NONHUMAN; PROTEINASE INHIBITION; RAT;

ADRENERGIC ALPHA-AGONISTS; AGMATINE; ANIMALS; BENZAMIDINES; CATALYTIC DOMAIN; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; LIGANDS; MALE; MODELS, CHEMICAL; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; SERINE PROTEINASE INHIBITORS; TRYPSIN;

ANIMALIA;

EID: 0036879167     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540215672     Document Type: Article

References (31)

1. Szabo, B. (2002) Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol. Ther. 93, 1-35.
2. Eglen, R. M., Hudson, A. L., Kendall, D. A., Nutt, D. J., Morgan, N. G., Wilson, V. G., and Dillon, M. P. (1998) Seeing through a glass darkly: casting light on imidazoline 1 sites. Trends Pharmacol. Sci. 19, 381-390.
3. 1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling. Ann. N.Y. Acad. Sci. 763, 22-42.
4. 1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J. Hypertens. Suppl. 15, S9-S23.
5. +1. J. Pharmacol. Exp. Ther. 276, 359-364.
6. 1 receptors, cardiovascular function, and metabolism. Am. J. Hypertens. 14, 317S-321S.
7. 3H]clonidine binding sites in rat stomach: high affinity of imidazolines, guanidines and sigma ligands. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 561-564.
8. 1-imidazoline sites in bovine adrenal medullary membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 70-76.
9. Palkhiwala, S. A., Yu, A., and Frishman, W. H. (2000) Imidazoline receptor agonist drugs for treatment of systemic hypertension and congestive heart failure. Heart Dis. 2, 83-92.
10. Reis, D. J., and Regunathan, S. (2000) Is agmatine a novel neurotransmitter in brain? Trends Pharmacol. Sci. 21, 187-193.
11. Ascenzi, P., Fasano, M., Marino, M., Venturini, G., and Federico, R. (2002) Agmatine oxidation by copper amine oxidase. Eur. J. Biochem. 269, 884-892.
12. Ascenzi, P., Amiconi, G., Bode, W., Bolognesi, M., Coletta, M., and Menegatti, E. (1995) Proteinase inhibitors from the European medicinal leech Hirudo medicinalis: structural, functional and biomedical aspects. Mol. Aspects Med. 16, 215-313.
13. Hörn, H., and Heidland, A. (Eds.) (1992) Proteases: potential role in health and diseases. Plenum, New York.
14. Casale, E., Collyer, C., Ascenzi, P., Balliano, G., Milla, P., Viola, F., Fasano, M., Menegatti, E., and Bolognesi, M. (1995) Inhibition of bovine β-trypsin, human α-thrombin and porcine pancreatic β-kallikrein-B by 4′,6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study. Biophys. Chem. 54, 75-81.
15. Glossmann, H., and Ferry, D. R. (1985) Assay for calcium channels. Methods Enzymol. 109, 513-550.
16. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270, 9856-9861.
17. 2-imidazoline sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 252-257.
18. 1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinase C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK). J. Neurochem. 79, 931-940.
19. Bradford, M. M. (1976) A rapid, sensitive method for the quantification of mg quantities of protein, utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
20. Antonini, E., and Brunori, M. (1971) Hemoglobin and Myoglobin in their Reactions with Ligands. North Holland Publishing Co., Amsterdam.
21. Barrett, A. J., Rawlings, N. D., and Woessner, J. F. (Eds.) (1998) Handbook of Proteolytic Enzymes. Academic Press, San Diego.
22. Bode, W., and Huber, R. (1992) Natural protein proteinase inhibitors and their interaction with proteinases. Eur J. Biochem. 204, 433-451.
23. Bode, W., and Huber, R. (2000) Structural basis of the endoproteinaseprotein inhibitor interaction. Biochim. Biophys. Acta 1477, 241-252.
24. Billstrom, A., Hartley-Asp, B., Lecander, I., Batra, S., and Astedt, B. (1995) The urokinase inhibitor p-aminobenzamidine inhibits growth of a human prostate tumor in SCID mice. Int. J. Cancer 61, 542-547.
25. Tuck, A. B., Hota, C., and Chambers, A. F. (2001) Osteopontin (OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent. Breast Cancer Res. Treat. 70, 197-204.
26. Festuccia, C., Teti, A., Bianco, P., Guerra, F., Vicentini, C., Tennina, R., Villanova, I., Sciortino, G., and Bologna, M. (1997) Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma. Oncol. Res. 9, 419-431.
27. Orthner, C. L., Kolen, B., and Drohan, W. N. (1993) A sensitive and facile assay for the measurement of activated protein C activity levels in vivo. Thromb. Haemost. 69, 441-447.
28. Nastruzzi, C., Gambari, R., Menegatti, E., Walde, P., and Luisi, P. L. (1990) Tumor cell growth inhibition by liposome-encapsulated aromatic polyamidines. J. Pharm. Sci. 79, 672-677.
29. Bernkop-Schnurch, A. (1998) The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Control Release 52, 1-16.
30. Venturini. G., Menegatti, E., and Ascenzi, P. (1997) Competitive inhibition of nitric oxide synthase by p-aminobenzamidine, a serine proteinase inhibitor. Biochem. Biophys. Res. Commun. 232, 88-90.
31. Cortesi, R., Ascenzi, P., Colasanti, M., Persichini, T., Venturini, G., Bolognesi, M., Pesce, A., Nastruzzi, C., and Menegatti, E. (1998) Crossenzyme inhibition by gabexate mesylate: formulation and reactivity study. J. Pharm. Sci. 87, 1335-1340.